TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for...
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, ophthalmic, and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types; TRC205 created for the treatment of fibrotic diseases; and TRC102, a small molecule that is in clinical development made for...
KEEP ON STRONG WATCH FOR A BREAKOUT ON CONTINUATION AFTER A SEVERAL STRONG TRADING SESSIONS. ALERT SET FOR BREAK OF $.91 FOR PROJECTED TARGET OF $1.30. SPECULATIVE AND RISKY.
AVERAGE ANALYSTS PRICE TARGET $1.50
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
COMPANY PROFILE
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted...
TCON quick slide down; divergence on ROC means quick reversion down to trend line then assumed return to upwards trend. Scalp with close takes profits a stop losses.
Trade responsibly; TPs and SLs.
keeping it simple!
We have seemed to reach the bottom 2$ mark once again, and have indicators of a bounce to the top of the wedge, and possible breakout!
I see the moku cloud turning bullish slightly, and buy signals in this area firing.
We had a weekly sqeeze fire short, which seems to be slowing down right about now, with noticable increased volume over the...
